Clinical Trial

Effects of Glycemic Control and Clinical Parameters on Tibial Nerve Conduction Latency in Diabetic Peripheral Neuropathy

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational cross-sectional study aims to investigate the effects of glycemic control and clinical parameters on tibial nerve conduction latency in individuals with diabetic peripheral neuropathy. Adults aged 45 to 76 years with diabetic peripheral neuropathy will be evaluated at a neurology and clinical neurophysiology clinic. Data collection will include demographic and clinical characteristics, diabetes type and duration, fasting blood glucose, and HbA1c values obtained from routine clinical records. Participants will also be assessed using the Michigan Neuropathy Screening Instrument (MNSI), including both the questionnaire and physical examination components. Nerve conduction studies will be performed using standard electromyography procedures, and tibial nerve conduction latency will be recorded. The study will examine the relationship between tibial nerve conduction latency and glycemic control parameters, neuropathy screening scores, and diabetes duration. The findings may help improve early identification and clinical evaluation of diabetic peripheral neuropathy.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Enrolling by Invitation 2026-04-24
Trial Details
NCT Number NCT07525882
Lead Sponsor Fenerbahce University
Conditions Diabetic Peripheral Neuropathy, Diabetes Mellitus
Enrollment 50 participants
Start Date 2026-04-13
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-23